CZ144895A3 - Triazoloquinazolines for treating diseases of central nervous system - Google Patents

Triazoloquinazolines for treating diseases of central nervous system

Info

Publication number: CZ144895A3
Authority: CZ; Czechia
Prior art keywords: triazoloquinazolines; central nervous; pct; nervous system; treating diseases
Prior art date: 1992-12-10

Application number

CZ951448A

Other languages

English (en)

Inventor

Rainer Schlecker

Hans-Jorg Treiber

Berthold Behl

Hans Peter Hofmann

Original Assignee

Basf Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-12-10

Filing date

1993-12-06

Publication date

1995-12-13

1993-12-06 Application filed by Basf Ag filed Critical Basf Ag

1995-12-13 Publication of CZ144895A3 publication Critical patent/CZ144895A3/cs

Links

208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
210000003169 central nervous system Anatomy 0.000 title 1
201000010099 disease Diseases 0.000 title 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

CZ951448A 1992-12-10 1993-12-06 Triazoloquinazolines for treating diseases of central nervous system CZ144895A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4241564A DE4241564A1 (de)	1992-12-10	1992-12-10	Triazolochinazoline zur Behandlung zentralnervöser Erkrankungen

Publications (1)

Publication Number	Publication Date
CZ144895A3 true CZ144895A3 (en)	1995-12-13

Family

ID=6474850

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CZ951448A CZ144895A3 (en)	1992-12-10	1993-12-06	Triazoloquinazolines for treating diseases of central nervous system

Country Status (13)

Country	Link
US (1)	US5612344A (cs)
EP (1)	EP0673249B1 (cs)
JP (1)	JPH08504418A (cs)
KR (1)	KR950703962A (cs)
AT (1)	ATE177637T1 (cs)
AU (1)	AU673225B2 (cs)
CA (1)	CA2151241A1 (cs)
CZ (1)	CZ144895A3 (cs)
DE (2)	DE4241564A1 (cs)
MX (1)	MX9307837A (cs)
NZ (1)	NZ258887A (cs)
WO (1)	WO1994013294A1 (cs)
ZA (1)	ZA939229B (cs)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH490362A (de) *	1967-04-03	1970-05-15	Upjohn Co	Verfahren zur Herstellung von 20-Ketosteroidverbindungen
DE3146599A1 (de) *	1981-11-25	1983-07-07	Basf Ag, 6700 Ludwigshafen	Neue triazolochinazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
EP0181282A1 (de) *	1984-10-01	1986-05-14	Ciba-Geigy Ag	Triazolochinazolinverbindungen
US4713383A (en) *	1984-10-01	1987-12-15	Ciba-Geigy Corporation	Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
US5153196A (en) *	1991-06-05	1992-10-06	Eli Lilly And Company	Excitatory amino acid receptor antagonists and methods for the use thereof

1992
- 1992-12-10 DE DE4241564A patent/DE4241564A1/de not_active Withdrawn
1993
- 1993-12-06 CA CA002151241A patent/CA2151241A1/en not_active Abandoned
- 1993-12-06 EP EP94902687A patent/EP0673249B1/de not_active Expired - Lifetime
- 1993-12-06 CZ CZ951448A patent/CZ144895A3/cs unknown
- 1993-12-06 NZ NZ258887A patent/NZ258887A/en unknown
- 1993-12-06 KR KR1019950702355A patent/KR950703962A/ko not_active Withdrawn
- 1993-12-06 AU AU56965/94A patent/AU673225B2/en not_active Ceased
- 1993-12-06 DE DE59309469T patent/DE59309469D1/de not_active Expired - Fee Related
- 1993-12-06 JP JP6513758A patent/JPH08504418A/ja active Pending
- 1993-12-06 US US08/433,509 patent/US5612344A/en not_active Expired - Fee Related
- 1993-12-06 WO PCT/EP1993/003424 patent/WO1994013294A1/de not_active Ceased
- 1993-12-06 AT AT94902687T patent/ATE177637T1/de not_active IP Right Cessation
- 1993-12-09 ZA ZA939229A patent/ZA939229B/xx unknown
- 1993-12-10 MX MX9307837A patent/MX9307837A/es unknown

Also Published As

Publication number	Publication date
DE59309469D1 (de)	1999-04-22
JPH08504418A (ja)	1996-05-14
CA2151241A1 (en)	1994-06-23
AU5696594A (en)	1994-07-04
MX9307837A (es)	1994-07-29
ATE177637T1 (de)	1999-04-15
DE4241564A1 (de)	1994-06-16
ZA939229B (en)	1995-06-09
WO1994013294A1 (de)	1994-06-23
NZ258887A (en)	1997-06-24
KR950703962A (ko)	1995-11-17
AU673225B2 (en)	1996-10-31
EP0673249B1 (de)	1999-03-17
EP0673249A1 (de)	1995-09-27
US5612344A (en)	1997-03-18

Publication	Publication Date	Title
AU6039194A (en)	1994-08-29	Imidazopyridines and their use in treating gastrointestinal diseases
TW238305B (cs)	1995-01-11
HU9402647D0 (en)	1994-11-28	The use of 4-aminopyridine for treating neurological conditions
ZA949593B (en)	1996-06-03	N-substituted azabicycloheptane derivatives their preparation and use
TW261614B (cs)	1995-11-01
DE59308187D1 (en)	1998-04-02	Substituierte ortho-ethenylphenylessigsäurederivate
CZ144895A3 (en)	1995-12-13	Triazoloquinazolines for treating diseases of central nervous system
DE59409813D1 (de)	2001-09-06	Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen
DK0646113T3 (cs)	1997-02-24
HU9501691D0 (en)	1995-08-28	New triazoloquinazolines, their production and their use
SI0729469T1 (en)	1998-12-31	IMIDAZO (1,5-a)QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS
GR3025682T3 (en)	1998-03-31	Anti-inflammatory macrolactam (cyclamenol).
TW252043B (cs)	1995-07-21